Literature DB >> 24018814

Acquired carbapenemases in Enterobactericeae in Singapore, 1996-2012.

Tse Hsien Koh1, Delphine Cao, Quek Yen Shan, Anna Bacon, Li-Yang Hsu, Eng Eong Ooi.   

Abstract

AIMS: To characterise carbapenemase-producing Enterobacteriaceae (CRE) isolated in Singapore.
METHODS: Carbapenemase genes and their flanking regions were amplified and sequenced by PCR. Isolates were typed by pulsed-field gel electrophoresis and multi-locus sequence typing. Plasmids bearing carbapenemase genes were sized by S1 nuclease digestion, Southern blotting, and DNA hybridisation with appropriate probes. Transfer of these plasmids was attempted by conjugation and transformation. Successfully transferred plasmids were characterised by polymerase chain reaction (PCR) replicon typing and restriction digestion.
RESULTS: Isolates of Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae and Citrobacter species carried a variety of carbapenemase genes including blaIMP-1, blaIMP-4, blaNDM-1, blaNDM-7, blaOXA-181, blaOXA-48 and blaKPC-2. Apart from K. pneumoniae with blaOXA-181, and some K. pneumoniae with blaNDM-1, the other isolates were not clonal. However there appears to be some spread of plasmids with blaIMP-1, blaNDM-1,blaKPC-2, and blaOXA-48.
CONCLUSIONS: The number of isolates of CRE has increased in Singapore, especially since 2010. There is a diversity of carbapenemase types that reflects the geographical proximity of other countries with CRE.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24018814     DOI: 10.1097/PAT.0b013e3283650b1e

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  17 in total

1.  In Vitro Activities of Ceftazidime-Avibactam, Aztreonam-Avibactam, and a Panel of Older and Contemporary Antimicrobial Agents against Carbapenemase-Producing Gram-Negative Bacilli.

Authors:  Shawn Vasoo; Scott A Cunningham; Nicolynn C Cole; Peggy C Kohner; Sanjay R Menon; Kevin M Krause; Kelly A Harris; Partha P De; Tse Hsien Koh; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

2.  Rapid and simple identification of carbapenemase genes, bla NDM, bla OXA-48, bla VIM, bla IMP-14 and bla KPC groups, in Gram-negative bacilli by in-house loop-mediated isothermal amplification with hydroxynaphthol blue dye.

Authors:  Arpasiri Srisrattakarn; Aroonlug Lulitanond; Chotechana Wilailuckana; Nicha Charoensri; Lumyai Wonglakorn; Pimjai Saenjamla; Prajuab Chaimanee; Jureerut Daduang; Aroonwadee Chanawong
Journal:  World J Microbiol Biotechnol       Date:  2017-06-05       Impact factor: 3.312

Review 3.  Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia.

Authors:  Li-Yang Hsu; Anucha Apisarnthanarak; Erum Khan; Nuntra Suwantarat; Abdul Ghafur; Paul Anantharajah Tambyah
Journal:  Clin Microbiol Rev       Date:  2016-10-19       Impact factor: 26.132

4.  In vitro pharmacodynamics of various antibiotics in combination against extensively drug-resistant Klebsiella pneumoniae.

Authors:  Tze-Peng Lim; Yiying Cai; Yanjun Hong; Eric Chun Yong Chan; Sasikala Suranthran; Jocelyn Qi-Min Teo; Winnie Huiling Lee; Thean-Yen Tan; Li-Yang Hsu; Tse-Hsien Koh; Thuan-Tong Tan; Andrea Lay-Hoon Kwa
Journal:  Antimicrob Agents Chemother       Date:  2015-02-17       Impact factor: 5.191

5.  Identification of a phage-derived depolymerase specific for KL64 capsule of Klebsiella pneumoniae and its anti-biofilm effect.

Authors:  Min Li; Pei Li; Long Chen; Genglin Guo; Yuyi Xiao; Liang Chen; Hong Du; Wei Zhang
Journal:  Virus Genes       Date:  2021-06-22       Impact factor: 2.332

6.  In Vitro Activity of Imipenem-Relebactam and Ceftolozane-Tazobactam against Resistant Gram-Negative Bacilli.

Authors:  Suzannah M Schmidt-Malan; Avisya J Mishra; Ammara Mushtaq; Cassandra L Brinkman; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

7.  In Vitro Activity of Plazomicin Compared to Amikacin, Gentamicin, and Tobramycin against Multidrug-Resistant Aerobic Gram-Negative Bacilli.

Authors:  Wim A Fleischmann; Kerryl E Greenwood-Quaintance; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

8.  Extensive Capsule Locus Variation and Large-Scale Genomic Recombination within the Klebsiella pneumoniae Clonal Group 258.

Authors:  Kelly L Wyres; Claire Gorrie; David J Edwards; Heiman F L Wertheim; Li Yang Hsu; Nguyen Van Kinh; Ruth Zadoks; Stephen Baker; Kathryn E Holt
Journal:  Genome Biol Evol       Date:  2015-04-10       Impact factor: 3.416

9.  Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae.

Authors:  Patrick N A Harris; Mo Yin; Roland Jureen; Jonathan Chew; Jaminah Ali; Stuart Paynter; David L Paterson; Paul A Tambyah
Journal:  Antimicrob Resist Infect Control       Date:  2015-05-01       Impact factor: 4.887

10.  Epidemiology and molecular characterization of multidrug-resistant Gram-negative bacteria in Southeast Asia.

Authors:  Nuntra Suwantarat; Karen C Carroll
Journal:  Antimicrob Resist Infect Control       Date:  2016-05-04       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.